Professional Documents
Culture Documents
dynamic theory but seems to use it as a flexible guide, not as graph. Villeneuve attempts to define the various forms of
an armor against pragmatic and humanistic practice. physiological and pathological anxiety. stating that drug
In my own current fields ofspecial interest, family therapy treatment should be reserved for the latter. He also points up
and marital therapy, I found Bentovims and Dominians some of the problems in classification of psychotropic drugs
chapters to be most lucid and sensible statements. Each of- and suggests that a new term, anxioleptic, should be used
fers good clinical illustrations that reveal the vitality of those instead of tranquilizer to designate specifically a class of
modalities. Dr. Blochs presentation of group therapy, al- drugs whose primary clinical action is anxiolytic, preferably
ways an extremely difficult thing to do, could not be done without inducing sedation: i.e. , without notable effect on
better in a brief presentation. Bancrofts and Gelders papers psychomotor activity and/or vigilance.
about behavior therapy and sex therapy are areas about Villeneuve also emphasizes that the majority of tests used
which I am least familiar, but I found the writing clean and to screen potential psychotropic agents in animals have little
the ideas sensible. Although the range of papers implies cc- or no relationship to the value ofthese drugs in humans. He
lecticism, the brand is a substantial one. The authors reflect points out that anxiolysis is not an exclusive pharmaco-
their essentially English origins through uncomplicated and logic property and can be produced without drugs. This fact
lucid use oftechnical language. Although I am not an Anglo- can make the clinical evaluation of the efficacy of tranquil-
phile, I must admit I was impressed. izers more difficult. Villeneuve feels that there is a definite
qualitative and quantitative difference between the sedative
SAUL L. BROWN, M.D. and anxiolytic action of many psychotropic agents, although
Los Angeles. Calif. this difference is not easy to establish.
Janke and his coworkers review the research in the dif-
ferential psychopharmacology of tranquilizing and sedating
Downs Syndrome: The Psychology of Mongolism, by David agents. These authors are well aware of the importance of
Gibson. New York, N. Y. , Cambridge University Press, individual variation among patients and its effect on the ad-
1978, 360 pp. , $42.50. ministration of psychotropic drugs. They arc also cognizant
of the shortcomings of their review in that it deals only with
Professor Gibson provides an integrated study of the most single dose administration in normal subjects, although the
recent biological and psychological research on the nature authors refer throughout the paper to results with patients
and management of Downs syndrome. Eighteen of his pa- receiving pharmacotherapy. Nevertheless, their analysis of
pers are listed in the extensive bibliography, testifying to his the nondrug factors influencing results with drug treatment is
broad research interest in the field. exhaustive and excellent. The chapter suffers slightly from
The introduction underlines the magnitude ofthe problem, using an outline format, which adds little to the presentation,
which affects approximately I in 600 children born and costs and from an overabundance of detailed charts and figures
the United States between $1 and $2 billion annually. The that are, at times, unnecessary and confusing. The bibliogra-
authors intention is to identify links between biological and phy, however. is extensive and useful.
psychological phenomena, which arc elaborated in chapters Simon and Soubnie review the animal literature on at-
covering early psychological development and dimensions tempts to differentiate between the anxiolytic and sedative
and foundations of intelligence, including studies connecting activity oftranquilizing drugs. They conclude that it is often
karyotypes and IQ. The author concludes that the sources but not always possible to separate sedative and anti-anxiety
of the variability of intelligence remain undetermined and effects. After their extensive review of the animal literature
that IQ and development can only partly be based on cyto- these conclusions leave one with a feeling of mild dis-
genetic data. appointment.
The chapters on personality, socialization, learning, and In a departure from the subject matter of the title of the
language provide a basis for the section on behavior manage- book, Valzelli reports on the effects of sedatives and anx-
ment. The stereotyped fear that Downs syndrome consti- iolytics on aggressivity in animals. The ability to control cx-
tutes an unalterable state exercises an inhibiting influence on cessive or pathological aggression is a subject of increasing
the approach to management. Dr. Gibson stresses that the importance and considerable clinical significance. Valzelli
syndrome is not defined at birth and proposes useful and examines the effects on aggressive behavior in animals of
maturationally specific programs of early intervention. It is two major categories of drugs: I ) sedative drugs. which in-
my hope that this important reference book will help to dude antihistamines, barbiturates, phenothiazines, buty-
correct psychiatrys disinterest in an important aspect of rophenones, and reserpine derivatives, and 2) anxiolytic
mental retardation. drugs, which include meprobamate and benzodiazcpines. He
points out the complicating factors ofgroup behavior and the
PHILIPPE F. CHANEL. M.D. importance of certain types of aggressive action in self-pre-
Washington. D.C. servative and mating activities.
One of Valzellis most interesting observations is that al-
most all drugs that have some anti-aggressive properties are
Modern Problems of Pharmacopsychiatry, Vol. 14: Dif- also capable of increasing aggressive behavior in both labo-
ferential Psychopharmacology of Anxiolytics and Sedatives, natory animals and man. These aggressogenic effects usu-
edited by J.-R. Boissier. Basel, S;titzerland, S. Karger, ally occur at much lower doses than those used to control or
1979, /73 pp., $35.25. ameliorate anti-aggressive effects.
The final chapter, by Schallek and Schlosser, reviews the
This volume attempts to determine whether the anxiolytic neuropharmacology of sedatives and anxiolytics. Although
properties of tranquilizers can be separated from their seda- not ofimmediate use to the clinician, its value to researchers
tive effects. The clinical value of minimizing or eliminating regarding the possible sites ofaction ofthese drugs is consid-
annoying side effects from a drug while still maintaining its erable. Animal experiments indicate that barbiturates induce
calming effects is obvious. Five papers comprise this mono- their sedative effects by depressing the reticular activating
1629
BOOK REVIEWS Am J Psychiatry /36:12, December 1979
system in the rostral brain stem. Anxiolytic drugs intended tween short-term and long-term patients one and two years
to reduce anxiety at doses that do not cause sedation or sleep after discharge.
(propanediols such as meprobamate) may act by depressing The authors summarize the clinical implications of their
deactivating centers in the caudal brain stem, releasing the study as follows: 1) for most patients with schizophrenia and
activating centers in the rostral brain stem and thus depress- for all patients with neurosis and personality disorder there
ing the thalamic recruiting response, and by depressing the is no clear advantage of a length of stay longer than four
amygdala or hippocampus. These effects may release the re- weeks, 2) schizophrenic patients who have functioned well
ticular formation from inhibition. Recent research has re- before hospitalization tend to drop out of aftercare programs
vealed a specific binding site for benzodiazepines in the brain that provide psychotherapy; one way to encourage patients
of the rat. Barbiturates, in sharp contrast, do not bind to to persist in aftercae is to extend hospitalization beyond two
these sites. to four weeks so that a firm connection to aftercare treat-
This excellent review of present-day research efforts to ment can be established, 3) schizophrenic patients who did
differentiate between the anxiolytic and sedative effects of not function well before they were hospitalized tend to stay
psychotropic drugs substantiates that much has been accom- in treatment after brief hospitalization and should therefore
pushed in attempting to make this differentiation but that the be hospitalized for a short period of time.
ideal anxiolytic has not yet been developed. Much more re- I feel that this study begins to provide some solutions
search must be done before a clinically significant difference to problems that currently face the field of psychiatry
between anxiolytics and sedatives can be established. and need to be answered in the l980s. The authors are to be
congratulated for their important contribution to this goal.
SIDNEY MALITZ, M.D.
Ne%t York, N. Y. GEORGE W. BARTHOLOW, M.D.
Omaha, Neb.
1630